NM_004490.3:c.1247C>T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004490.3(GRB14):c.1247C>T(p.Thr416Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,476 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T416A) has been classified as Uncertain significance.
Frequency
Consequence
NM_004490.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRB14 | NM_004490.3 | c.1247C>T | p.Thr416Ile | missense_variant | Exon 11 of 14 | ENST00000263915.8 | NP_004481.2 | |
GRB14 | NM_001303422.2 | c.986C>T | p.Thr329Ile | missense_variant | Exon 10 of 13 | NP_001290351.1 | ||
GRB14 | XM_047444013.1 | c.647C>T | p.Thr216Ile | missense_variant | Exon 10 of 13 | XP_047299969.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461310Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 726932 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152166Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74320 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1247C>T (p.T416I) alteration is located in exon 11 (coding exon 11) of the GRB14 gene. This alteration results from a C to T substitution at nucleotide position 1247, causing the threonine (T) at amino acid position 416 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at